Steven Boyd
CIK 1706140 · last filed 2022-05-19
Steven Boyd is a corporate insider who has filed 62 SEC Form 4 insider transactions across 15 companies since 2017. The most recent filing, for TENX, was dated May 19, 2022. Across all open-market trades the lifetime net is +$30.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.11B across reported positions. 239 SEC filings were submitted jointly with ARMISTICE CAPITAL, LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.11B
15
62
$30.94M
Filer Profile
NEW YORK, NY 10022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TENX | Director | 2,330 | $1.86 | $4.3K | $1.54M | 4 | 2022-05-19 |
| AVTX | Director | 16,424 | $16.12 | $264.8K | $39.40M | 3 | 2022-03-07 |
| Vyome Holdings, Inc (RSLS) Delisted | 10%+ Owner | 7 | $15.68 | $110 | -$28.46M | 1 | 2021-06-22 |
| Vaxart, Inc. (VXRT) Delisted | Director | 15,600,000 | $0.32 | $4.99M | -$53.29M | 7 | 2020-06-03 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | 52,418,772 | $2.93 | $153.59M | $28.90M | 7 | 2020-03-16 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | 10%+ Owner | 8,138,000 | — | — | $20.47M | 3 | 2020-01-13 |
| Valeritas Holdings Inc. (VLRX) Delisted | 10%+ Owner | 0 | — | — | -$1.73M | 4 | 2019-12-23 |
| AYTU | Director | 79,240 | $1.99 | $157.7K | $203.2K | 1 | 2019-12-23 |
| Del Frisco's Restaurant Group, Inc. (DFRG) Delisted | Director | 6,260,000 | — | — | $13.27M | 6 | 2019-05-09 |
| BIO-PATH HOLDINGS, INC. (BPTH) Delisted | 10%+ Owner | 12,930 | $0.04 | $453 | -$514.9K | 1 | 2019-01-23 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | 10%+ Owner | 620,000 | — | — | -$5.64M | 2 | 2019-01-14 |
| CASSAVA SCIENCES INC (PTIE) Delisted | 10%+ Owner | 4,336,000 | — | — | -$3.83M | 1 | 2018-08-20 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | Director | 34,960,000 | — | — | $16.58M | 7 | 2018-08-20 |
| EYEG | 10%+ Owner | 32,745,000 | $33.99 | $1.11B | $3.96M | 2 | 2018-04-27 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 924,267 | $5.54 | $5.12M | $68.4K | 1 | 2018-02-09 |
Recent Filings
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-19 | TENX | Mixed | — | $0 | EDGAR |
| 2022-03-07 | AVTX | Buy (P) | +1,530,000 | $1.03M | EDGAR |
| 2022-02-22 | AVTX | Buy (P) | +864,000 | $694.7K | EDGAR |
| 2021-09-17 | AVTX | Buy (P) | +17,100,000 | $37.67M | EDGAR |
| 2021-07-09 | TENX | Grant (A) | — | $0 | EDGAR |
| 2021-06-22 | — | Other (J) | −15,990,831 | $0 | |
| 2021-06-22 | Vyome Holdings, Inc (RSLS) Delisted | Sell (S) | −4,606,938 | -$28.46M | EDGAR |
| 2020-11-04 | — | Buy (P) | +9,300 | $33.1K | |
| 2020-09-22 | — | Buy (P) | +9,900 | $40.9K | |
| 2020-09-16 | — | Mixed | +300 | $1.1K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.